An imaging, guidance, planning and treatment system integrated into a single unit or assembly of components, and a method for using same, that can be safely and effectively deployed to treat Benign Prostatic Hyperplasia in ail medical settings, including in a physician's office or in an outpatient setting. The system utilizes the novel process of Radio-Frequency Electrical Membrane Breakdown (“EMB” or “RFEMB”) to destroy the cellular membranes of unwanted BPH tissue without damaging sensitive anatomical structures in the prostate. The system preferably comprises at least one EMB treatment probe 20, at least one ultrasound scanner, at least one trackable anesthesia needle 300, and at least one controller unit for at least partially automating the treatment process.